Piers Blombery

6.1k citations

122 papers · 2.4k indexed · 1 hit paper · h-index 26

Impact in

Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Hematology top 1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments

Papers in

Genetics 51
- Chronic Lymphocytic Leukemia Research 37
- Myeloproliferative Neoplasms: Diagnosis and Treatment 11
Hematology 41
- Acute Myeloid Leukemia Research 31
- Chronic Myeloid Leukemia Treatments 12

Co-authors: David Westerman Ella R. Thompson Andrew W. Roberts John F. Seymour Mary Ann Anderson Constantine S. Tam David C.S. Huang Thomas E. Lew
Journals: Blood (29 papers)Blood Advances (13 papers)British Journal of Haematology (9 papers)Haematologica (5 papers)Leukemia (4 papers)
Partner nations: Australia United States Germany

In The Last Decade

Piers Blombery

106 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia 2018 · 276 citations

Peers

Countries citing papers authored by Piers Blombery

Since Specialization

Citations

This map shows the geographic impact of Piers Blombery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piers Blombery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piers Blombery more than expected).

Fields of papers citing papers by Piers Blombery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piers Blombery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piers Blombery. The network helps show where Piers Blombery may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Piers Blombery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Piers Blombery Line = papers co-authored together Piers Blombery links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Integrative analysis of the tumour immune microenvironment of breast implant-associated anaplastic large cell lymphoma using multi-omics Blood ·Criselle D’Souza, Niko Thio, Luciana Baptista Pereira, Heshani Desilva, Piers Blombery, Ella R. Thompson, Anand K. Deva, H. Miles Prince, Paul J. Neeson	2025	0
2	Genomic variation in DDX41 identified through clinical sequencing British Journal of Haematology ·Jan Łazor, Ing Soo Tiong, Sally M. Hunter, Nicole den Elzen, Liu Maji, 尚文加藤, Francesco M. Raimonodo, Ella R. Thompson, Michelle Tan, Catherine Soubiran, Lucy C. Fox, Piers Blombery	2025	0
3	Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice Leukemia ·Piers Blombery, Thomas Chatzikonstantinou, 刘方喜, Richard Rosenquist, Gianluca Gaïdano, Šárka Pospı́šilová, Andrew W. Roberts, Richard W. Birkinshaw, Davide Rossi, Lydia Scarfò, John F. Seymour, Stephan Stilgenbauer, Adrian Wiestner, Jennifer A. Woyach, Intan Seprina Anugrah, Paolo Ghia, Κώστας Σταματόπουλος	2025	0
4	Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma Blood Advances ·Sasanka M. Handunnetti, Amit Khot, Piers Blombery, Kate Burbury, Philip A. Thompson, David Ritchie, Rodney J. Hicks, Hans-Christoph Diener, Rachel Koldej, Mathias Bressel, I. Cameron, David Westerman, Stephen Lade, Andrew W. Roberts, John F. Seymour, Constantine S. Tam, Mary Ann Anderson	2025	0
5	Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC) Journal of Clinical Oncology ·Ing Soo Tiong, Devendra Hiwase, Almostafa Zayed, Ashish Bajel, BhagwanSwarup Gupta, C Stank, John Reynolds, Natasha S. Anstee, Tamia Nguyen, Sun Loo, Chong Chyn Chua, Michael Ashby, Clay Jayne, Shaun Fleming, Chun Yew Fong, 弘資赤羽, Piers Blombery, Richard Dillon, Adam Ivey, Andrew H. Wei	2024	18
6	Acquired BCL2 variants associated with venetoclax resistance in acute myeloid leukemia Blood Advances ·Fiona C. Brown, X. Tao, Richard W. Birkinshaw, Chong Chyn Chua, Michael D. Hvidsten, K.V. Deepadevi, Giovanna Pomilio, Piers Blombery, David C.S. Huang, Peter E. Czabotar, Marcelo Yaksic Vera, Guang Yang, Martin Carroll, Andrew H. Wei, Alexander E. Perl	2024	7
7	Analysis of 3760 hematologic malignancies reveals rare transcriptomic aberrations of driver genes Genome Medicine ·Pingbing Zuo, Sandra Huber, Luis Luengo-Baranguan, Franziska R. Traube, Marc Seifert, Christopher C. Oakes, Andrea L. Waggoner, Shashirekha C.H, Ines F. Scheller, Nils Wagner, Vicente A. Yépez, Piers Blombery, Torsten Haferlach, Matthias Heinig, Leonhard Wachutka, Stephan Hütter, Julien Gagneur	2024	1
8	Evaluation of T‐cell clonality by anti‐TRBC1 antibody‐based flow cytometry and correlation with T‐cell receptor sequencing British Journal of Haematology ·Phillip Nguyen, Tamia Nguyen, Yuanji Xu, Ing Soo Tiong, 방수현, Vuong Nguyen, Neil Came, Piers Blombery, David Westerman	2023	2
9	Targeting the BRAF pathway in haematological diseases Internal Medicine Journal ·Wing‐Keung Cheung, Michael Dickinson, James E. Paterson, P. Peter Benudiz, Andrew Grigg, John J. Moore, Piers Blombery, John F. Seymour	2023	3
10	Allogeneic stem cell transplantation achieves long-term remissions in mantle cell lymphoma, including in TP53 -mutated disease Leukemia & lymphoma ·Thomas E. Lew, Edward R. Scheffer Cliff, Michael Dickinson, Constantine S. Tam, John F. Seymour, Piers Blombery, Ashish Bajel, David Ritchie, Amit Khot	2023	5
11	Biallelic deleterious germline SH2B3 variants cause a novel syndrome of myeloproliferation and multi‐organ autoimmunity SHILAP Revista de lepidopterología ·Piers Blombery, Vahid Pazhakh, Adriana S. Albuquerque, Jesmeen Maimaris, Serhii Dobrovolskyi, Jiang Yu-song, Mosher, Ella R. Thompson, Ben Carpenter, Ian Proctor, Julie Curtin, Jonathan Lambert, Siobhan O. Burns, Graham J. Lieschke	2023	8
12	Functional interaction between compound heterozygous TERT mutations causes severe telomere biology disorder Blood Advances ·Flores Benito, مجتبى رفیعیان, Agung Maulana, Lucy C. Fox, Piers Blombery, Raja S. Vasireddy, Hilda A. Pickett, Julie Curtin, Pasquale Barbaro, Jonathan Rodgers, Xuan Liu, Lisa G. Riley, Jessica K. Holien, Scott B. Cohen, Tracy M. Bryan	2022	2
13	ALLSorts: an RNA-Seq subtype classifier for B-cell acute lymphoblastic leukemia Blood Advances ·Laura A. Martinez-Espinoza, Lauren M. Brown, Georgina L. Ryland, Andrew Lonsdale, 陆永刚, Louise Ludlow, Ian J. Majewski, Piers Blombery, Paul G. Ekert, N. Davidson, Alicia Oshlack	2022	27
14	Transient, flexible gene editing in zebrafish neutrophils and macrophages for determination of cell-autonomous functions Disease Models & Mechanisms ·G A van Eikema Hommes, Zuobing Zhang, Vahid Pazhakh, 田洪春, Ella R. Thompson, Lucy C. Fox, Ross Cook, Piers Blombery, Graham J. Lieschke	2021	11
15	Undetectable peripheral blood MRD should be the goal of venetoclax in CLL, but attainment plateaus after 24 months Blood Advances ·Thomas E. Lew, Mary Ann Anderson, Victor S. Lin, Sasanka M. Handunnetti, Neil Came, Piers Blombery, David Westerman, Meaghan Wall, Constantine S. Tam, Andrew W. Roberts, John F. Seymour	2020	31
16	High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot Journal for ImmunoTherapy of Cancer ·Simon P. Keam, Heloise M. Halse, Thu Quynh Nguyen, Minyu Wang, Federico Siviero, Catherine Mitchell, Franco Caramia, David J. Byrne, Sue Haupt, Georgina L. Ryland, Phillip K. Darcy, Shahneen Sandhu, Piers Blombery, Ygal Haupt, Scott Williams, Paul J. Neeson	2020	51
17	First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study Cancer Discovery ·Amit Khot, Natalie Brajanovski, Donald P. Cameron, Nadine Hein, Kylee Maclachlan, Elaine Sanij, John K. C. Lim, John Soong, Emma Link, Piers Blombery, Ella R. Thompson, Andrew Fellowes, Karen E. Sheppard, Grant A. McArthur, Richard B. Pearson, Ross D. Hannan, Gretchen Poortinga, Simon J. Harrison	2019	132
18	Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia Cancer Discovery ·Piers Blombery, Mary Ann Anderson, Jianan Gong, Rachel Thijssen, Richard W. Birkinshaw, Ella R. Thompson, Charis E. Teh, Tamia Nguyen, Zhen Xu, Christoffer Flensburg, Thomas E. Lew, Ian J. Majewski, Daniel H.D. Gray, David Westerman, Constantine S. Tam, John F. Seymour, Peter E. Czabotar, David C.S. Huang, Andrew W. Roberts Hit paper breakdown →	2018	276
19	Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura British Journal of Haematology ·Christopher J. Patriquin, Mari Thomas, Tina Dutt, Siobhan McGuckin, Piers Blombery, Tanya Cranfield, C. T. Moreira, Marie Scully	2016	60
20	Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders Haematologica ·Piers Blombery, Stephen Q. Wong, Chelsee Hewitt, Alexander Dobrovic, Ellen Maxwell, Surender Juneja, G. Grigoriadis, David Westerman	2011	52

About Piers Blombery

Piers Blombery is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Oncology and Immunology, having authored 122 papers that have together received 2.4k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (37 papers), Lymphoma Diagnosis and Treatment (35 papers), Acute Myeloid Leukemia Research (31 papers), Cancer Genomics and Diagnostics (12 papers), Chronic Myeloid Leukemia Treatments (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), CAR-T cell therapy research (11 papers) and Acute Lymphoblastic Leukemia research (10 papers). The work is most often cited by research in Genetics (890 citations), Hematology (749 citations), Pathology and Forensic Medicine (606 citations), Immunology (653 citations) and Oncology (675 citations). Piers Blombery has collaborated with scholars based in Australia, United States and Germany. Frequent co-authors include David Westerman, Ella R. Thompson, Andrew W. Roberts, John F. Seymour, Mary Ann Anderson, Constantine S. Tam, David C.S. Huang, Thomas E. Lew, H. Miles Prince and Ian J. Majewski. Their work appears in journals such as Blood, Blood Advances, British Journal of Haematology, Haematologica and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact